Discovering drugs to treat coronavirus disease 2019 (COVID-19)
Qingdao University · Affiliated Hospital of Qingdao University
Indexed incrossrefpubmed
Abstract
The SARS-CoV-2 virus emerged in December 2019 and then spread rapidly worldwide, particularly to China, Japan, and South Korea. Scientists are endeavoring to find antivirals specific to the virus. Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19) in China; some promising results have been achieved thus far. This article summarizes agents with potential efficacy against SARS-CoV-2.
Citation impact
1,454
total citations
- FWCI
- 35.98
- Percentile
- 100%
- References
- 21
Citations per year
Authors
3Topics & keywords
Topics
Keywords
- Favipiravir
- Coronavirus disease 2019 (COVID-19)
- Coronavirus
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- Medicine
- Disease
- Virology
- 2019-20 coronavirus outbreak
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.